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Background: Oral leukoplakia is the most common potentially malignant disorder (PMD) of the oral cavity. The 
objectives of this study are to determine the clinicopathologic features in a group of patients with oral leukoplakia 
of Northern Spain (Galicia), determining the factors associated to clinical risk and analyzing the malignant trans-
formation of these patients.
Material and Methods: We included 85 patients. We recorded sex and age, habits like alcohol and tobacco, size, 
clinical appearance, site, number of lesions,  and presence or absence of dysplasia. We assess the association 
between risk factors and transformation and developed a logistic regression analysis. Finally we used the Kaplan-
Meier and log-rank test for the survival analysis. 
Results: 7 patients (8.2%)  had malignant transformation. The mean follow-up of the  patients was 4.13 years  ver-
sus 5.58 years of those who developed carcinoma. Only location and initial dysplasia have a statistically significant 
relationship with malignant transformation, but when applied the long rank test only the presence of dysplasia 
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Conclusions: We found that the presence of dysplasia is the only risk factor that is statistically related to the develop-
ment of a carcinoma.
Key words: Leukoplakia, oral cancer and oral precancer, follow-up, malignant transformation.
Introduction
Oral leukoplakia is the most common potentially ma-
lignant lesion of the oral cavity, it is estimated that the 
overall prevalence is 1.72-2.60% (1). It is defined as “a 
white plate of questionable risk, having excluded (other) 
known diseases or disorders that do not increase the 
risk of cancer” (2).
Most leukoplakia lesions are benign lesions.  A per-
centage of these acquire progressive dysplastic changes 
(3) and finally can result in the development of a car-
cinoma (4). The percentage of malignancy varies from 
one study to another, reaching a range from 0.13% (5) 
to 34% (6);  if we consider only the form of proliferative 
verrucous leukoplakia can reach 70.3.% (7).  Today we 
still don’t have the means at our disposal that allows us 
to know the prognosis of an individual lesion (8,9).
In literature there are certain risk factors associ-
ated with malignant transformation such as advanced 
age (3,10,11), female sex (12), idiopathic leukoplakia 
(non-smokers) (11,13), long evolution (14), size above 
200mm2 (15,16) or length of major axis of more than 
4 mms (17), non homogeneous clinical form (11,18,19), 
the subsite of tongue and floor of the mouth (20) and the 
presence of dysplasia  (10,21-23). But the results vary 
when we compare different studies. 
The objectives of this study are to determine the clinical 
and pathological features of leukoplakia of the oral cav-
ity in our area in a group of 85 patients from Northern 
Spain (Galicia), and identifying the factors associated to 
malignant transformation and doing  a study of survival 
of patients with this disease.
Material and Methods
-Patients
Patients clinically diagnosed with oral leukoplakia were 
selected from the database of patients who attended the 
Oral Medicine Unit Clinic of the School of Dentistry 
at the University of Santiago de Compostela between 
January 1995 and June 2010. 
This study complied with the Helsinki Declaration. The 
study received the approval of the ethics committee of 
the Galician Department of Health .
-Inclusion and exclusion criteria
Patients with clinical leukoplakia lesions (as defined by 
the WHO(2) in 2005:” white plaques of questionable 
risk having excluded (other) known diseases or disor-
ders that carry no increased risk for cancer”) were in-
cluded, such cases were confirmed by incisional or ex-
cisional biopsy (diagnostic certainty 3 and 4, using Van 
der Waal’s classification), of which we obtained access 
to the clinical history, clinical images of the lesion and 
the anatomic-pathological material.
Exclusion criteria were: 1) Lack of initial histological 
diagnosis; 2) follow-up period of less than one year; 3) 
lesion with clinical appearance or histological findings 
white, or predominantly white, benign disease such as 
leukoedema, linea alba, potentially malignant lesions 
such as lichen planus, discoid lupus erythematosus, etc. 
4) lack of initial clinical image of the lesion; 5) lack of 
access to the histological material allowing for confir-
mation of the initial diagnosis; 6) presence of a concom-
itant carcinoma or diagnosed within 6 months after the 
initial diagnosis.
Of the 90 patients who met the inclusion requirements 
established for the study, we excluded 5 who showed 
a carcinoma in the first biopsy or who were diagnosed 
with one in less than 6 months after their first visit. 
-Clinical data
Demographic data (sex and age) and clinical data rel-
evant to leukoplakia (location (according to the ICD-
10 recommendations (2,24)) were recorded, as well as 
the clinical form following the WHO’s classification 
(2,24). In order to determine the size of the lesion fol-
lowing Van der Waal (25,26), we recorded the size of 
the lesion based on the length of the major axis, thus 
differentiating three groups (0-2 cms, 2-4cms and >4 
cms), and finally, single or multiple location (affecting 
more than one subsite). All these data were collated 
from the clinical records, in some cases the form and 
size were determined using clinical photograps from 
the lesions.
The information on toxic habits, such as smoking (27), 
we divided them into two groups, smokers and non-
smokers, and included in the former current smokers and 
those who had been smokers in the past 10 years; and in 
the latter, those who have never smoked or have quit over 
10 years prior. As for alcohol, we decided to classify pa-
tients as a drinkers and non-drinkers, since in most medi-
cal records the amounts are not registered. 
Follow-up was performed every 6 or 3 months, depend-
ing on the characteristics of the lesion, to assess progress.
-Histopathologic examination 
All patients in the study underwent biopsies at the time 
of initial diagnosis and, in some cases, during the fol-
low up, if changes that were likely to become malignant 
were observed.
The biopsied tissue was fixed in 10% formaldehyde, 
subsequently embedded in paraffin and processed for 
routine histological study using the hematoxylin-eosin 
technique. 
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Once the tissues were collected, all cases were assessed 
again by the same oral pathologist  and further con-
firmed by an independent observer. 
Gradation of dysplasia was evaluated according to the 
criteria of the WHO (28) and classified as mild, moderate 
and severe. For the survival study, we transformed this 
variable into a binary: absence / presence of dysplasia.
-Statistical study
All data collected was entered into a database using Mi-
crosoft Office Excel 2007 for Windows. Subsequently, 
the data was tabulated and analyzed statistically using 
SPSS software for Windows, version 20.0 (SPSS Inc., 
Chicago, IL, USA).
We carried out a descriptive analysis of clinical and 
pathological factors. In order to compare means, we 
used the t student test or the ANOVA single-factor test.
To assess the association between risk factors and trans-
formation, we transformed the variables into binary op-
tions and used the Pearson chi-square test or Fisher’s 
exact test, when the frequency for a given variable was 
less than 5. We also developed a logistic regression 
analysis to assess the effect of risk.
For the survival analysis, we used the Kaplan-Meier and 
log-rank tests to assess if the generated survival curves 
were significantly different. The study time was consid-
ered the time from the completion of the first biopsy to 
the development of cancer (non-censured observation) 
or until the end of the patient follow-up (censored ob-
servation).
All p-values (P) are bilateral, and p-values of 0.05 or 
less are considered as significant.
Results
-Patient characteristics  
The group of 85 patients consisted of 45 men and 40 
women, with an average age of 58.68 years (SD = 12.88, 
and range from 22 to 85). 
The most frequently affected site was the tongue (37.6%) 
followed by gum and buccal mucosa, both in 22.4% of 
patients. 57.6% of leukoplakia were non homogeneous 
and, within these, nodular leukoplakia (29.4%) was the 
most common and 55.3% had more than one affected 
location. For the initial diagnosis, 62.4% of the biopsies 
were incisional, while 37.6% were excisional. 44.7% 
of patients were smokers, the mean daily consumption 
was of 24.08 units (SD ± 16.63), with minimum and 
maximum values of 2 and 100, respectively, the case of 
the smoker accounting for two units he smoked cigars. 
73.7% were heavy smokers (smoking more than 20 ciga-
rettes). Smoking was more frequent in the group of men 
(73.7%). As for alcohol consumption, this information 
was not included in the medical history of 7 patients; 
of the drinkers (35.9%), men accounted for 67.9% con-









Lip (C00) 3 (3.5)
Tongue (C02) 32 (37.6)
Gum (C03) 19 (22.4)
Floor of the mouth (C04) 7 (8.2)
Palate (C05) 5 (5.9)
Buccal mucosa (C06) 19 (22.4)
Clinical subtype
Homogeneous 36 (42.4)















   Unknown 7 (8.2)
   Non-drinker 50 (64.1)








Table 1: Characteristics of the studied population. 
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-Clinical characteristics and relationship with malig-
nant transformation 
Table 2 presents the results from comparing the clini-
cal characteristics between patients who do not suffer 
transformation and those who did. The men/women af-
fectation ratio was 1.1 / 1 for the group in general, when 
assessing the number of cases that have become malig-
Risk factors No. Patients Histopathologic diagnosis
No CA CA P
Sex 0.702
   Men 45 (52.9) 42 (93.3) 3 (6.7)
   Women 40 (47.1) 36 (90) 4 (10)
Age (years) 1.000
   <60 43 (50.6) 39 (90.7) 4 (9.3)
   >60 42 (49.4) 39 (92.9) 3 (7.1)
Location 0.044*
  Other locations 46 (54.1) 45 (97.8) 1 (2.2)
  Tongue and floor of the mouth 39 (45.9) 33 (84.6) 6 (15.4)
Clinical subtype 0.230
   Homogeneous 36 (42.4) 35 (97.2) 1 (2.8)
   Non Homogeneous 49 (57.6) 43 (87.8) 6 (12.2)
Size of lesion 1.000
   <2cm 40 (47.1) 37 (92.5) 3 (7.5)
   ≥2cm 45 (52.9) 41 (91.1) 4 (8.9)
No of lesions 1.000
   Simple 38 (44.7) 35 (92.1) 3 (7.9)
   Multiple 47 (55.3) 43 (91.5) 4 (8.5)
Smoking habits 0.124
   Non-smoker 47 (55.3) 41 (87.2) 6 (12.8)
Smoker 38 (44.7) 37 (97.4) 1 (2.6)
Alcohol consumption 1.000
   Unknown 7 (8.2) 7 (100) --
   No drinker 50 (64.1) 45 (90) 5 (10)
   Drinker 28 (35.9) 26 (92.9) 2 (7.1)
Initial histopathologic diagnosis 0.026*
   None 59 (91.8) 57 (96.6) 2 (3.4)
  Dysplasia 26 (30.6) 21 (80.8) 5 (19.2)
Total 85 78 (91.8) 7 (8.2)
Table 2: Distribution (%) of risk factors and histopathologic diagnosis of the 85 patients and p-values of risk comparison.
nant, the ratio is reversed to 1: 1.3, with women suffer-
ing from higher levels of malignant transformation. 
The mean age at end of follow-up was 64.14 (95% CI 
(53.76 to 74.53)) for the group that develops carcinoma 
and the average age in the group that does not develop 
the event at the end of follow-up was 62.69 (95% CI 
(59.68 to 65.69)). When applying the ANOVA mean 
comparison test, we note that there are no differences 
between the two groups.
Table 2 shows that only two of the risk factors: loca-
tion and initial histological diagnosis have a statistically 
significant relationship with malignant transformation. 
The tongue and floor of mouth are the preferred loca-
tions of malignancy as well as patients with dysplasia at 
diagnosis. In patients without dysplasia at the beginning 
of the treatment, we must emphasize that one developed 
cancer 11 months after the first visit, He was a 38 year 
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old male, who smoked over 20 cigarettes per day, which 
contrasts with the other case, a non-smoking 58.8 year 
old woman who developed a carcinoma 11 years later.
Of the 7 patients who suffered malignant transforma-
tion, carcinoma develops in areas of previous lesions 
except in a case in which leukoplakia appears in the lat-
eral surface of the tongue and the carcinoma develops 
in the ipsi-lateral alveolar ridge and there was no previ-
ous lesion. Two other cases where the initial biopsy was 
taken at one location and  a carcinoma is developed in a 
different location but is affected by leukoplakia.
-Histopathologic studies of samples
Of the leukoplakia cases showing dysplasia at the initial 
visit:  19 were mild (21.1%), 4 moderate (4.4%) and 3 
severe (3.3%). 
-Survival analysis
In our study, 7 (8.2%) of the 85 patients had malignant 
transformation. The mean follow-up of the 85 patients 
was 4.13 years (95% CI:  (3.36 to 4.89)) versus 5.58 
years (95% CI: (1.15 to 10.02)) of those who developed 
carcinoma. 
As we can observe in Figure 1, the Kaplan Meier sur-
vival curve for all lesions of the general group without 
distinction by risk factors. We can see how most of the 








Table 3: Proportion of oral cancer free 
survival (OCFS), in which SE is standard 
error, throughout the check-ups at 1, 5, 7, 
8, and 11 years.
Fig. 1: Kaplan Meier curve analysis of malignant transformation.
In table 3 we see the proportion of malignant transfor-
mation free survival (OCFS) during the follow-up at 1, 
5, 7, 8 and 11 years. Thus, we see that at 5 years, 96.3% 
of the sample was free of transformation. The rate of 
malignancies at 5 years was 3.7%, as the follow-up pe-
riod increases, so does the number of transformations. 
We can also see how OCFS takes different values when 
calculated according to the degree of dysplasia and lo-
cation (Table 4). In patients without dysplasia we have 
estimated an OCFS at five years of 98.3% (0.017) com-
pared to 92.1 (0.053) of the group having dysplasia. For 
other factors, considering them as independent vari-
ables, we conducted a study of binary logistic regres-
sion to measure risk, considering  malignant transfor-
mation as a dependent variable (Table 5).
In Figures 2 and 3, survival curves regarding these risk 
factors: localization and dysplasia. By comparing the 
curves with the log rank test, the significance in terms 
of location (P = 0.058) disappears, in which only the 
presence of dysplasia remains statistically significant (P 
= 0.026). 
Therefore, in our samples, we found that the presence 
of dysplasia is the only risk factor that is statistically 
related to the development of a carcinoma.
Discussion
Precancerous lesions, leukoplakia in particular, is a dif-
ficult field of study due to changes in the nomenclature 
and definition since they were first described until now. 
Also, there are no established criteria for epidemiologi-
cal study, so we find recommendations (25,29-31).
Many authors studied oral dysplasia regardless of the 
clinical lesion from which the samples were taken from, 
treating all potentially malignant disorders equally. 
Few articles carried out the study of oral leukoplakia 
lesions exclusively and consider only dysplasia from it 
(4). If we know that the lesion having higher chances 
of malignization is leukoplakia, we should not treat all 
dysplasias equally, because in this way we could draw 
erroneous conclusions regarding the behavior of a par-
ticular clinical lesion. Even within leukoplakia we can 
see different behaviors depending on the consumption 
habits related to their etiology, as is the case of con-
sumption of betel nut, very rare in our society, which is 
a carcinogenic factor in itself, or in the case of smoking, 
it would be necessary to establish a criteria first with 
respect to a classification by smoking habits.
For this reason, we have solely analyzed the lesions that 
meet the clinical criteria of leukoplakia with anatomic-
pathological confirmation. 
The rate of malignant transformation, when evaluat-
ing all the leukoplakia, regardless of the degree of dys-
plasia appearing varies widely from 0.13% to 17.9% 
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Characteristics Malignization/Total OCFs percentage at 5 
years (SE)
OCFs percentage at 11 
years (SE)
All patients (85) 7/85 96.3 (0.021) 73.9 (0.122)
Location of lesion
    Other locations 1/46 - 75.0 (0.217)
    Tongue/floor of the mouth 6/39 92.2 (0.043) 46.9 (0.213)
Initial dysplasia diagnosis
   None 2/59 98.3 (0.017) 81.9 (0.150)
   Any 5/26 92.1 (0.053) 31.6 (0.240)




OR IC 95% p value
Sex (men) 1.55 0.32-7.40 0.579
Age (≥60) 1.33 0.28-6.35 0.728
Tobacco (smoker) 5.41 0.62-47.00 0.126
Alcohol (non-drinker) 1.44 0.26-7.98 0.673
Clinical form (homogeneous) 4.88 0.56-42.49 0.151
Size (<2) 1.2 0.252-5.73 0.816
Number of lesions (one) 1.08 0.22-5.17 0.91
Table 5: Analysis of logistic regression of the risk of developing carcinoma for independent variables.
Fig. 2: Kaplan-Meier curve for location and period free from malig-
nant transformation.
Fig. 3: Kaplan-Meier curve for dysplasia and period free from ma-
lignant transformation.
(5,13,18,23,32,33). In our study, 7 of the 85 patients suf-
fered malignant transformation representing a transfor-
mation ratio of 8.2%. Other authors found similar indi-
ces such as Amagasa (10) with a rate of 7.9%.
Regarding the mean follow-up in our group, it was 4.14, 
while it amounted to 5.58 years in those patients who 
suffered malignant transformation. With these results 
we can conclude that the longer the follow-up time 
the higher the risk of transformation into carcinoma, 
as has been shown by other studies (11,13). Authors 
such as Silverman found a conversion ratio of 6% in 
its first research and by increasing the follow-up period 
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it increased to 17.5% (13). Lummerman(34) observed 
a transformation of dysplastic lesions in 33.6 months 
and Ho MW (16) observed a mean follow-up time of 48 
months, from the first visit to the transformation.
Most studies described cases of appearance of carcino-
mas that were distant from the initially described leuko-
plakia (3,11,34). Some authors also describe remote ma-
lignizations far from the areas affected by leukoplakia 
in oral mucosa of normal appearance  (6,34), all facts 
supporting the theory of field malignant transformation. 
Like other authors (6,34), we found a case of a patient 
who developed cancer in a remote location of normal-
appearing mucosa that was not affected by leukoplakia. 
Lee (3) observed that in 41% of patients the cancer was 
developed in areas far from the initial lesion, this can 
be explained by the theory of field cancerization (35), 
according to which any area of mucosa exposed to car-
cinogens can develop premalignant changes. Thomson 
(36) found dysplastic areas in remote areas of the initial 
lesion and with the appearance of normal oral mucosa 
in 15 patients. In contrast to our results, Brouns (17)  de-
scribes that all carcinomas arose in the same location as 
the initial leukoplakia.
The malignant transformation free period or Oral Cancer 
Free survival (OCFS)  at 5 years was 96.3 (0.021) and 
73.9 (0.122) at 11 years. Very few studies calculating the 
rate of transformation in OCFS, which would be ideal to 
compare populations, thus we should consider the follow-
up time of patients so that the rate of malignant transfor-
mation is time-person dependent. We only agreed with 
Liu (18) in the malignant transformation free period, 
which differentiates when initial lesions are low risk or 
high risk, and found a low risk OCFS of 90.6% (95% CI 
0.86-0.96) and high risk 61.7% (95% CI 0.44-0.80). As 
in our study, when we consider the dysplasia-free group 
we found a greater OCFS than in patients with dysplasia.
The distribution by sex shows a male / female ratio of 
1.1:1 similar to other studies (20,34,37). However, this 
index is inverted when we analyze the cases of malig-
nization, 1: 1.3 (men/women), despite this we did not 
find statistically significant differences in malignization 
like other authors (17,38), but we did find a higher pro-
portion of women who developed carcinoma (6,17,23).
No relationship between the location of the leukoplakia 
and a greater transformation was found, although the 
statistically significant association between localization 
in the tongue and malignization is described in the liter-
ature (23). We must keep in mind that most OSCC cases 
arise from the floor of the mouth, the soft palate and 
the ventral / lateral tongue surface (39). Epithelia lin-
ing the high cancerization risk areas are associated with 
dysplasia more frequently (40).  The trend of dysplasia 
has been associated to high risk areas to include genetic 
alterations (loss of heterozygosity LOH at 3p and/or 9p) 
with a high risk of progression (41) .
Conclusions
The clinicopathological characteristics of the studied 
leukoplakia in our area were consistent with those found 
by other authors from countries of Western Europe. We 
found that non homogeneous lesions pose a risk of de-
veloping a carcinoma almost 5 times higher compared 
to homogeneous lesions Although initially it seemed 
that the two factors related to the malignant transforma-
tion of leukoplakia were the subsite and the presence 
of dysplasia, ultimately the only factor clearly associ-
ated with malignant transformation is the presence of 
dysplasia of any kind either mild, moderate or severe. 
The survival analysis results underline the importance 
of comprehensive monitoring of these patients and the 
need to carefully observe any changes that occur in any 
area of the oral cavity of the patients diagnosed with 
leukoplakia.
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